1. Home
  2. EVO vs GRPN Comparison

EVO vs GRPN Comparison

Compare EVO & GRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • GRPN
  • Stock Information
  • Founded
  • EVO 1993
  • GRPN 2008
  • Country
  • EVO Germany
  • GRPN United States
  • Employees
  • EVO N/A
  • GRPN N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • GRPN Advertising
  • Sector
  • EVO Health Care
  • GRPN Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • GRPN Nasdaq
  • Market Cap
  • EVO 1.4B
  • GRPN 1.2B
  • IPO Year
  • EVO 2021
  • GRPN 2011
  • Fundamental
  • Price
  • EVO $4.15
  • GRPN $19.94
  • Analyst Decision
  • EVO Strong Buy
  • GRPN Buy
  • Analyst Count
  • EVO 1
  • GRPN 4
  • Target Price
  • EVO $7.00
  • GRPN $31.25
  • AVG Volume (30 Days)
  • EVO 42.9K
  • GRPN 1.2M
  • Earning Date
  • EVO 11-05-2025
  • GRPN 11-06-2025
  • Dividend Yield
  • EVO N/A
  • GRPN N/A
  • EPS Growth
  • EVO N/A
  • GRPN N/A
  • EPS
  • EVO N/A
  • GRPN N/A
  • Revenue
  • EVO $912,894,891.00
  • GRPN $487,747,000.00
  • Revenue This Year
  • EVO N/A
  • GRPN $4.78
  • Revenue Next Year
  • EVO $10.78
  • GRPN $10.96
  • P/E Ratio
  • EVO N/A
  • GRPN N/A
  • Revenue Growth
  • EVO N/A
  • GRPN N/A
  • 52 Week Low
  • EVO $2.84
  • GRPN $7.75
  • 52 Week High
  • EVO $5.64
  • GRPN $43.08
  • Technical
  • Relative Strength Index (RSI)
  • EVO 63.61
  • GRPN 37.34
  • Support Level
  • EVO $4.05
  • GRPN $19.60
  • Resistance Level
  • EVO $4.27
  • GRPN $21.12
  • Average True Range (ATR)
  • EVO 0.09
  • GRPN 0.98
  • MACD
  • EVO 0.01
  • GRPN 0.04
  • Stochastic Oscillator
  • EVO 73.91
  • GRPN 12.59

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

Share on Social Networks: